ARMOGARD 150

What is ARMOGARD 150?

ARMOGARD 150 is a prescription medication from the group of psychostimulants and wakefulness-promoting agents (so-called agents that stimulate the activity of the cerebral cortex without a pronounced amphetamine-like effect). The drug is available in the form of tablets for oral administration, each containing 150 mg of the active substance armodafinil. The manufacturer is the Indian pharmaceutical company Fortune Healthcare, which specializes in the production of generic drugs in accordance with Good Manufacturing Practice (GMP) standards. The tablets have a protective coating that ensures the stability of the active substance and convenience of intake.

According to the pharmacological classification, ARMOGARD 150 belongs to agents that affect the "sleep-wake" cycle. Unlike classic psychostimulants, the drug acts selectively: it increases alertness and concentration without causing pronounced motor excitement, tremor, or a sharp increase in blood pressure. That is why armodafinil in international practice is considered an agent with a moderate addiction potential compared to amphetamines. However, this does not mean the absence of risks — medical supervision remains a prerequisite for therapy.

The 150 mg dosage is considered standard therapeutic and is intended primarily for adult patients with diagnosed disorders of excessive daytime sleepiness. Tablets are usually available in blisters of 10 pieces, which allows strict adherence to the prescribed course. It is important to understand that ARMOGARD 150 is not a means "to increase productivity" in healthy people and does not replace full sleep. Its use is justified only when a specific medical cause of pathological sleepiness has been established.

What is ARMOGARD 150 prescribed for?

The main indication for prescribing ARMOGARD 150 is narcolepsy — a chronic neurological disorder in which the regulation of sleep phases is disrupted, and a person suddenly falls asleep during the day, regardless of the circumstances. The drug helps to reduce the number of daytime sleep episodes and increase the overall level of daytime activity. In addition, it is used for obstructive sleep apnea syndrome as an adjunctive therapy to the main treatment (for example, CPAP therapy) when residual sleepiness persists despite device-assisted breathing correction. Important: armodafinil does not treat apnea itself and does not eliminate sleep-disordered breathing.

The third classic indication is shift work sleep disorder. It develops in people who regularly work night shifts — medical workers, dispatchers, production operators, long-distance drivers. In such patients, the internal circadian rhythm conflicts with the work schedule, leading to chronic sleepiness and reduced working capacity. ARMOGARD 150 in this case helps to maintain the necessary level of alertness during the work shift.

In clinical practice, the drug is sometimes considered as a component of complex therapy for chronic fatigue syndrome and severe asthenia against the background of other diseases; however, such prescriptions are considered off-label use and require an especially thorough assessment of the benefit-risk ratio. Any independent decision to start taking it without an established diagnosis is dangerous. Before using ARMOGARD 150, a consultation with a neurologist or sleep specialist with appropriate examination is required.

Composition and active components of ARMOGARD 150

The active substance of the drug is armodafinil at a dose of 150 mg. Armodafinil is the R-enantiomer of modafinil, that is, the "dextrorotatory" molecular form, which has a longer half-life and provides a more stable plasma concentration throughout the day. Due to this, the effect occurs faster and lasts longer compared to the racemic mixture. This specific feature allows the drug to be taken once daily.

The mechanism of action of armodafinil is not fully understood, but it has been established that it weakly and selectively inhibits dopamine reuptake in the synaptic cleft, increasing its extracellular concentration in brain regions responsible for wakefulness. Additionally, the substance affects the orexin and histaminergic systems of the hypothalamus — key regulators of the sleep-wake cycle. The result is an increased level of alertness, improved concentration, and a reduced subjective feeling of fatigue. At the same time, the peripheral sympathomimetic effect is significantly less pronounced than that of traditional stimulants.

Excipients of the tablet usually include lactose monohydrate, microcrystalline cellulose, corn starch, povidone, croscarmellose sodium, and magnesium stearate. These substances have no pharmacological activity of their own, but ensure the formation of the tablet, its disintegration in the stomach, and the release of the active substance. Patients with lactose intolerance or celiac disease should inform their doctor before being prescribed ARMOGARD 150.

Dosage of ARMOGARD 150

The standard adult dose is one tablet of ARMOGARD 150 (150 mg of armodafinil) once daily. For narcolepsy and residual sleepiness associated with sleep apnea, the drug is taken in the morning, immediately after waking up. For patients with shift work schedules, it is recommended to take the tablet approximately one hour before the start of the night shift. Exceeding the daily dose of 250 mg without a direct prescription from a doctor is strictly not recommended.

Dose adjustment is required for certain patient categories. In severe hepatic impairment, the dose is usually halved, as armodafinil is metabolized mainly in the liver. In elderly patients (over 65 years old), treatment is often started with a lower dose due to a possible decrease in drug clearance. In renal impairment, there are no special recommendations for dose adjustment; however, such patients require closer monitoring.

The duration of the course is determined exclusively by the doctor, depending on the nature of the underlying disease. In narcolepsy, therapy can be long-term; in shift work disorder, it may be situational. Periodically, it is necessary to reassess the effectiveness of treatment and the need for its continuation, as prolonged use may decrease response to the drug.

How to take ARMOGARD 150 correctly?

The tablet is swallowed whole, without chewing or crushing, with a sufficient amount of water. Food intake does not significantly affect the overall bioavailability of armodafinil, but may slightly delay the onset of the effect — therefore, if a rapid action is needed, it is better to take the drug on an empty stomach. It is important to adhere to the same time of administration daily to avoid disrupting your own circadian rhythm. Evening administration is strictly undesirable, as it can cause insomnia.

If a dose is missed and several hours have passed since the scheduled time, skip this dose and take the next one according to the schedule. Doubling the dose to compensate for a missed one is forbidden — this increases the risk of headache, tachycardia, and anxiety. Taking the drug late in the day is almost guaranteed to lead to difficulty falling asleep the following night.

During treatment, you should not abruptly stop taking the drug without consulting a doctor, especially after a long course. The reaction to armodafinil is individual: in some patients, the effect is pronounced from the very first days, while in others, an adaptation period is required. ARMOGARD 150 does not replace sleep hygiene — a full night's rest remains the foundation of therapy.

Side effects of ARMOGARD 150

The most common side effects are headache, nausea, dizziness, dry mouth, and insomnia. They are usually mild to moderate in severity and often decrease during the first weeks of therapy. Decreased appetite, dyspepsia, increased sweating, and irritability are also possible. In case of persistent discomfort, the doctor may adjust the dosage.

Uncommonly, tachycardia, increased blood pressure, anxiety, emotional lability, tremor, and paresthesia (tingling sensation in the limbs) are observed. Psychiatric disorders — agitation, aggressiveness, depressive manifestations, hallucinations, as well as suicidal ideation — are rarely reported. Patients with a psychiatric history require particularly careful supervision while taking ARMOGARD 150.

The most dangerous, although extremely rare, are severe skin reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis, drug rash with eosinophilia. The appearance of any rash, blisters, mucosal ulcers, swelling of the face, difficulty breathing, or fever requires immediate discontinuation of the drug and urgent medical attention. You should also consult a doctor in case of chest pain, arrhythmia, or a sharp change in mental status.

Contraindications of ARMOGARD 150

Absolute contraindications are individual hypersensitivity to armodafinil, modafinil, or any of the excipients, as well as a history of severe skin reactions to these substances. The drug is not prescribed for uncontrolled arterial hypertension, severe arrhythmias, unstable angina, recent myocardial infarction, and in left ventricular hypertrophy or mitral valve prolapse with clinical manifestations.

Relative contraindications include anxiety disorders, bipolar affective disorder, a history of psychosis, severe hepatic impairment, and past substance abuse. ARMOGARD 150 is not used in children and adolescents under 18 years of age due to insufficient evidence of safety and an increased risk of skin reactions. In elderly patients, therapy is prescribed with caution and under the control of cardiovascular parameters.

Pregnancy and breastfeeding are periods when taking the drug is not recommended due to the lack of sufficient safety data for the fetus and infant. Separately, it should be emphasized: armodafinil can reduce the effectiveness of hormonal contraceptives, so women of reproductive age should use additional or alternative methods of contraception during the course and for at least a month after its completion.

Interaction of ARMOGARD 150 with other drugs and alcohol

Armodafinil is an inducer of the CYP3A4 enzyme and an inhibitor of CYP2C19, so it affects the metabolism of many drugs. It can lower the concentration of cyclosporine, certain statins, calcium channel blockers, hormonal contraceptives, and antiepileptic agents. Conversely, concentrations of diazepam, phenytoin, omeprazole, and propranolol may increase, requiring adjustment of their doses. Concomitant use with MAO inhibitors, tricyclic antidepressants, and other stimulants increases the risk of hypertensive reactions and requires mandatory medical supervision.

Combining ARMOGARD 150 with alcohol is undesirable: ethanol depresses the central nervous system, negates the therapeutic effect of the drug, and increases the risk of headache, tachycardia, and unpredictable psychiatric reactions. Regarding driving and operating machinery — despite its stimulating effect, the drug does not guarantee full recovery of reaction speed in patients with narcolepsy. Before getting behind the wheel, make sure that your body's response to therapy is stable and predictable.

Where to buy ARMOGARD 150 in Ukraine

ARMOGARD 150 belongs to prescription-only medications in Ukraine. It can be purchased at specialized pharmacy establishments, as well as through online pharmacies that have appropriate licenses and deliver throughout the country. When ordering, you should pay attention to the presence of accompanying documentation, the original blister with batch marking and expiration date, which is a basic guarantee of quality.

Store the drug in a dry, dark place at a temperature not exceeding 25 °C, out of the reach of children. Do not use tablets after the expiration date or if the packaging is damaged. The final decision on prescribing ARMOGARD 150, dose selection, and course duration is made exclusively by a doctor after examination — the body's response to armodafinil is purely individual, and what proved effective for one person may be unacceptable for another.